Fluvoxamine, a common antidepressant, significantly reduces the persistent fatigue associated with long COVID, whereas the diabetes drug metformin proved ineffective.
Most Recent Articles
Precision Adjuvants and the Programming of Long-Lived Mucosal T-Cell Immunity
A new study reveals that "programming" T cells with bacterial-like signals can create long-lasting lung immunity, potentially leading to respiratory vaccines that stay effective against mutations for years.
Cysteine Partitioning as a Metabolic Regulator of CD8+ T-Cell Effector Function
Breakthrough study reveals that T cells use the nutrient cysteine to balance growth and killing power, offering a new metabolic target to prevent immune exhaustion in cancer patients.
Structural Strategies for Oral-Renal Integration in Chronic Disease Management
Emerging research reveals a dangerous bidirectional link between kidney disease and oral infections, calling for a unified medical approach to prevent transplant delays and slow renal decline.
Results of the CADENCE Study: Targeting Group 2 Pulmonary Hypertension
New Phase 2 study shows that the drug sotatercept successfully reduces lung blood pressure and improves heart function in patients with a severe form of heart failure.